Related Experiment Video
Updated: Aug 8, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
[BCG vaccination in France]
Bacille Calmette-Guérin (BCG) vaccination offers approximately 80% protection against tuberculosis for 15 years. However, BCG vaccination does not reduce tuberculosis transmission within the population.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Context:
- Bacille Calmette-Guérin (BCG) vaccination has been a cornerstone of tuberculosis control in France since 1950.
- Declining tuberculosis incidence raises questions about the ongoing efficacy and future role of BCG vaccination.
- The protective effectiveness of BCG vaccination is subject to ongoing debate and research.
Purpose:
- To evaluate the protective efficacy of Bacille Calmette-Guérin (BCG) vaccination against tuberculosis.
- To assess the duration of BCG-induced protection.
- To investigate the indirect effect of BCG vaccination on tuberculosis transmission within populations.
Summary:
- BCG vaccination demonstrates variable efficacy in human studies, with some showing 80% protection, others 30%, and some none.
- Methodological differences in studies influence efficacy results; studies with robust methodologies suggest approximately 80% protection lasting 15 years.
- BCG vaccination does not appear to reduce the transmission of tuberculosis bacilli, as evidenced by unchanged incidence in unvaccinated contacts.
Impact:
- Findings suggest BCG vaccination provides significant direct protection against tuberculosis for individuals.
- The lack of indirect protection highlights the need for continued public health measures alongside vaccination.
- Understanding BCG's limitations is crucial for refining global tuberculosis control strategies.
More Related Videos
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Vaccine Production
Vaccines
Smallpox